Abstract:Background: The COVID-19 pandemic has impacted the scope of health economics literature, which will increasingly examine value beyond health care interventions such as government policy and broad health system innovations. Aim: The study analyzes economic evaluations and methodologies evaluating government policies suppressing or mitigating transmission and reducing COVID-19, broad health system innovations, and models of care. This can facilitate future economic evaluations and assist government and public health policy decisions during pandemics. Methods: The Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) was used. Methodological quality was quantified using the scoring criteria in European Journal of Health Economics, Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Checklist and the National Institute for Health and Care Excellence's (NICE) Cost Benefit Analysis Checklist. PUBMED, Medline, and Google Scholar were searched from 2020-2021. Results: Cost utility analysis (CUA) and cost benefit analysis (CBA) analyzing mortality, morbidity, quality adjusted life year (QALY) gained, national income loss, and value of production effectively evaluate government policies suppressing or mitigating COVID-19 transmission, disease, and impacting national income loss. The WHO's pandemic economic framework facilitates economic evaluations of social and movement restrictions. Social return on investment (SROI) links benefits to health and broader social improvements. Multi-criteria decision analysis (MCDA) can facilitate vaccine prioritization, equitable health access, and technology evaluation. Social welfare function (SWF) can account for social inequalities and population-wide policy impact. It is a generalization of CBA, and operationally, it is equal to an equity-weighted CBA. It can provide governments with a guideline for achieving the optimal distribution of income, which is vital during pandemics. Economic evaluations of broad health system innovations and care models addressing COVID-19 effectively use cost effectiveness analysis (CEA) that utilize decision trees and Monte Carlo models, and CUAs that effectively utilize decision trees and Markov models, respectively. Conclusion: These methodologies are very instructive for governments, in addition to their current use of CBA and the value of a statistical life analytical tool. CUA and CBA effectively evaluate government policies suppressing or mitigating COVID-19 transmission, disease, and impacts on national income loss. CEA and CUA effectively evaluate broad health system innovations and care models addressing COVID-19. The WHO's framework, SROI, MCDA, and SWF can also facilitate government decision-making during pandemics. Supplementary information: The online version contains supplementary material available at 10.1007/s10389-023-01919-z.

Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review

The economics of the COVID-19 pandemic: economic evaluation of government mitigation and suppression policies, health system innovations, and models of care

Gauging the Impact of Artificial Intelligence and Mathematical Modeling in Response to the COVID-19 Pandemic: A Systematic Review

The role of economic evaluation in modelling public health and social measures for pandemic policy: a systematic review

COVID-19 mitigation strategies and overview on results from relevant studies in Europe

Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information

Modelling Methods of Economic Evaluations of HIV Testing Strategies in Sub-Saharan Africa: A Systematic Review

Open-sourced modeling and simulating tools for decision-makers during an emerging pandemic or epidemic - Systematic evaluation of utility and usability: A scoping review update

Retrospective analysis of Covid-19 hospitalization modelling scenarios which guided policy response in France

Cost-effectiveness of Interventions for the Prevention and Control of COVID-19: Systematic Review of 85 Modelling Studies

Modelling the impact of behavioural interventions during pandemics: A systematic review.

A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia

Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic

Assessing the impact of forced and voluntary behavioral changes on economic-epidemiological co-dynamics: A comparative case study between Belgium and Sweden during the 2020 COVID-19 pandemic

Lessons Learned in Using Mathematical Modeling for Priority Setting in Health

Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review

Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics

Counting the Costs of COVID-19: Why Future Treatment Option Values Matter

The unequal effects of the health-economy trade-off during the COVID-19 pandemic

Lessons on the Economics of Pandemics from Recent Research

The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic